Harga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)2.97
Harga Terendah (52 Minggu)1.03
Latar Belakang Perusahaan
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA drugs to treat and protect people from diseases associated with the human papillomavirus (HPV), cancer, and infectious diseases.
Summary
Valuation Information
Current PE Ratio (TTM)-0.7
Forward PE Ratio16.58
Current Price to Book Value15
Current Price to Sales-
EV to Revenue921.12
EV to EBITDA-1.09
PEG Ratio-
Per Share
Current EPS (Annualized)-1.58
Diluted EPS (TTM)-1.58
Revenue Per Share0
Current Book Value Per Share0.07
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-82358176
Profit Margin0
Operating Margin0

